181 related articles for article (PubMed ID: 38273860)
1. Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review.
Deng M; Zhang X; Xu C; Luo R; Chen L; Zhou Y; Hou Y
Pathol Oncol Res; 2023; 29():1611577. PubMed ID: 38273860
[No Abstract] [Full Text] [Related]
2. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].
Gómez Portilla A; Cendoya I; Muriel J; Olabarria I; Guede N; Moraza N; Fernández E; Martínez de Lecea C; Magrach L; Martín E; Romero E; Aguado I; Valdovinos M; Larrabide I
Cir Esp; 2007 Feb; 81(2):82-6. PubMed ID: 17306123
[TBL] [Abstract][Full Text] [Related]
3. Multicystic and diffuse malignant peritoneal mesothelioma in children.
Vermersch S; Arnaud A; Orbach D; Andre N; Berger C; Kepenekian V; Brigand C; Fresneau B; Poli-Merol ML; Habougit C; Varlet F; Scalabre A
Pediatr Blood Cancer; 2020 Jun; 67(6):e28286. PubMed ID: 32277799
[TBL] [Abstract][Full Text] [Related]
4. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.
Miyata T; Fujiwara Y; Nishijima K; Futagami F; Nakamura T; Takamura H
J Med Case Rep; 2019 Mar; 13(1):66. PubMed ID: 30879467
[TBL] [Abstract][Full Text] [Related]
5. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
7. [A case of malignant peritoneal mesothelioma successfully treated with concurrent chemoradiotherapy].
Hida K; Hashimoto K; Ishitani K; Maebayashi K; Mitsuhashi N; Matsui H
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2639-41. PubMed ID: 22189233
[TBL] [Abstract][Full Text] [Related]
8. [Peritoneal malignant mesothelioma: review and recent data].
Mery É; Hommell-Fontaine J; Capovilla M; Chevallier A; Bibeau F; Croce S; Dartigues P; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Poizat F; Robin N; Valmary-Degano S; Verriele-Beurrier V; Villeneuve L; Isaac S
Ann Pathol; 2014 Feb; 34(1):26-33. PubMed ID: 24630634
[TBL] [Abstract][Full Text] [Related]
9. 50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
Letica-Kriegel AS; Leinwand JC; Sonett JR; Gorenstein LA; Taub RN; Chabot JA; Kluger MD
Ann Surg Oncol; 2020 Jan; 27(1):205-213. PubMed ID: 31065962
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
de Boer NL; van Kooten JP; Burger JWA; Verhoef C; Aerts JGJV; Madsen EVE
BMJ Open; 2019 May; 9(5):e026779. PubMed ID: 31092657
[TBL] [Abstract][Full Text] [Related]
11. Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review.
Jiang Y; Mei Z; Cao H; Li S; Xu H; Qiu H; Liu Y
Cancer Biol Ther; 2019; 20(12):1409-1415. PubMed ID: 31411522
[TBL] [Abstract][Full Text] [Related]
12. Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature.
Stamou K; Tsamis D; Pallas N; Samanta E; Courcoutsakis N; Prassopoulos P; Tentes AA
Int J Hyperthermia; 2015; 31(8):850-6. PubMed ID: 26382910
[TBL] [Abstract][Full Text] [Related]
13. Ocular melanoma in a patient successfully treated for diffuse malignant peritoneal mesothelioma: a case report.
Langlais S; Velazquez-Martin JP; Dubé P; Simpson ER; Leblanc G; Sideris L
World J Surg Oncol; 2012 May; 10():90. PubMed ID: 22613358
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report.
Tang F; Cui Y; Gao Y
Medicine (Baltimore); 2024 Apr; 103(17):e37985. PubMed ID: 38669368
[TBL] [Abstract][Full Text] [Related]
15. Diffuse malignant peritoneal mesothelioma.
Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
Chirieac LR; Hung YP; Foo WC; Hofer MD; VanderLaan PA; Richards WG; Sugarbaker DJ; Bueno R
Cancer; 2019 Dec; 125(23):4164-4171. PubMed ID: 31390057
[TBL] [Abstract][Full Text] [Related]
17. [Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
Lao I; Chen Q; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):364-9. PubMed ID: 25208984
[TBL] [Abstract][Full Text] [Related]
18. Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.
Le Roy F; Gelli M; Hollebecque A; Honoré C; Boige V; Dartigues P; Benhaim L; Malka D; Ducreux M; Elias D; Goéré D
Ann Surg Oncol; 2017 Nov; 24(12):3640-3646. PubMed ID: 28849389
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
[TBL] [Abstract][Full Text] [Related]
20. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
Chapel DB; Stewart R; Furtado LV; Husain AN; Krausz T; Deftereos G
Hum Pathol; 2019 May; 87():11-17. PubMed ID: 30794891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]